NFKB1 and systemic lupus erythematosus: In SLE, certain probiotics are found to impede DC migration by downregulating of CCR7 and CXCR4 chemokine receptors through AhR and NF-κB pathway mechanisms thereby reducing their homing to lymph nodes and limiting autoreactive T-cells (108).